Search Results - "CHIBON, Frédéric"
-
1
Adult desmoid tumors: biology, management and ongoing trials
Published in Current opinion in oncology (01-07-2017)“…To summarize the current knowledge about the biology and clinical management of adult desmoid tumors. In the past decade, we have learned that desmoid tumors…”
Get full text
Journal Article -
2
Molecular prognostication of uterine smooth muscle neoplasms: From CGH array to CINSARC signature and beyond
Published in Genes chromosomes & cancer (01-03-2021)“…Uterine leiomyoma and leiomyosarcoma are located at the ends of the spectrum of smooth muscle lesions. Leiomyosarcoma belongs to the complex genomic sarcomas…”
Get full text
Journal Article -
3
A Global and Integrated Analysis of CINSARC-Associated Genetic Defects
Published in Cancer research (Chicago, Ill.) (01-12-2020)“…The Complexity Index in Sarcomas (CINSARC) signature is a transcriptomic marker that identifies high-risk soft-tissue sarcomas and is associated with high…”
Get full text
Journal Article -
4
MED12 and uterine smooth muscle oncogenesis: State of the art and perspectives
Published in European journal of cancer (1990) (01-08-2015)“…Abstract MED12 is a subunit of the multiprotein complex Mediator, an evolutionary-conserved regulator of transcription. Oncogenic mutations in exon 2 of MED12…”
Get full text
Journal Article -
5
Acquisition of cancer stem cell capacities after spontaneous cell fusion
Published in BMC cancer (07-03-2021)“…Cancer stem/Initiating cell (CS/IC) hypothesis argues that CS/ICs are responsible of tumour initiation, drug resistance, metastasis or disease relapse. Their…”
Get full text
Journal Article -
6
Grading of soft tissue sarcomas: from histological to molecular assessment
Published in Pathology (01-02-2014)“…Several histological grading systems for soft tissue sarcomas have been described since the early 1980s. Their main objective is to select patients for…”
Get full text
Journal Article -
7
Leiomyosarcomas: whole genome sequencing for a whole biology characterization
Published in Current opinion in oncology (01-07-2019)“…PURPOSE OF REVIEWLeiomyosarcoma (LMS) is among the more aggressive sarcomas and still suffers from the lack of efficient systemic treatment after, or before,…”
Get full text
Journal Article -
8
Genome remodeling upon mesenchymal tumor cell fusion contributes to tumor progression and metastatic spread
Published in Oncogene (21-05-2020)“…Cell fusion in tumor progression mostly refers to the merging of a cancer cell with a cell that has migration and immune escape capabilities such as…”
Get full text
Journal Article -
9
Fluorescence in situ hybridization analysis is a helpful test for the diagnosis of dermatofibrosarcoma protuberans
Published in Modern pathology (01-02-2015)“…Cytogenetically, most dermatofibrosarcoma protuberans are characterized by chromosomal rearrangements resulting in the collagen type-1 alpha 1…”
Get full text
Journal Article -
10
The CINSARC signature as a prognostic marker for clinical outcome in multiple neoplasms
Published in Scientific reports (14-07-2017)“…We previously reported the CINSARC signature as a prognostic marker for metastatic events in soft tissue sarcomas, breast carcinomas and lymphomas through…”
Get full text
Journal Article -
11
Special features of sarcomas developed in patients with Lynch syndrome: A systematic review
Published in Critical reviews in oncology/hematology (01-08-2023)“…Lynch syndrome (LS) is a genetic predisposition leading to colorectal and non-colorectal tumors such as endometrial, upper urinary tract, small intestine,…”
Get full text
Journal Article -
12
Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial
Published in BMC cancer (31-07-2020)“…The value of chemotherapy in soft tissue sarcoma (STS) remains controversial. Several expert teams consider that chemotherapy provides a survival advantage and…”
Get full text
Journal Article -
13
Biology and signaling pathways involved in the oncogenesis of desmoid tumors
Published in Bulletin du cancer (01-03-2020)“…Desmoid tumors (TDs) are derived from mesenchymal stem cells and their pathogenesis is strongly linked to the Wingless/Wnt cascade where the deregulation of…”
Get more information
Journal Article -
14
YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomas
Published in Genes chromosomes & cancer (01-12-2010)“…In a series of 404 adult soft tissue sarcomas, analyzed by array‐CGH, we have observed in approximately 10% of them a genomic amplification of either…”
Get full text
Journal Article -
15
Recurrent DMD Deletions Highlight Specific Role of Dp71 Isoform in Soft-Tissue Sarcomas
Published in Cancers (01-07-2019)“…Soft-tissue sarcomas (STS) are rare tumors whose oncogenesis remains unknown and for which no common therapeutic target has yet been identified. Analysis of…”
Get full text
Journal Article -
16
PRIMA-1(MET) induces death in soft-tissue sarcomas cell independent of p53
Published in BMC cancer (13-10-2015)“…The aim of this study was to explore the efficacy and define mechanisms of action of PRIMA-1(MET) as a TP53 targeted therapy in soft-tissue sarcoma (STS)…”
Get full text
Journal Article -
17
Robust gene expression signature is not merely a significant P value
Published in European journal of cancer (1990) (01-08-2013)Get full text
Journal Article -
18
Value and limitation of immunohistochemical expression of HMGA2 in mesenchymal tumors: about a series of 1052 cases
Published in Modern pathology (01-12-2010)“…The high mobility group A ( HMGA2 ) gene encodes a protein that alters chromatin structure and regulates the transcription of many genes; it is implicated in…”
Get full text
Journal Article -
19
Tetraploidization of Immortalized Myoblasts Induced by Cell Fusion Drives Myogenic Sarcoma Development with DMD Deletion
Published in Cancers (19-05-2020)“…Whole-genome doubling is the second most frequent genomic event, after alterations, in advanced solid tumors and is associated with poor prognosis…”
Get full text
Journal Article -
20
PRIMA-1MET induces death in soft-tissue sarcomas cell independent of p53
Published in BMC cancer (13-10-2015)“…Background The aim of this study was to explore the efficacy and define mechanisms of action of PRIMA-1.sup.MET as a TP53 targeted therapy in soft-tissue…”
Get full text
Journal Article